Monoclonal Antibodies to Human Lymphocytes

Clinical Application in the Therapy of Leukemia
  • Ronald Levy
  • Paul Stratte
  • Michael Link
  • David G. Maloney
  • Alan Oseroff
  • Richard A. Miller


It has long been hoped that antibodies directed against tumor cell surfaces could be exploited for therapy (Ehrlich, 1906). Because of their specificity and their cytotoxic effects, antibodies provide an appealing theoretical approach to cell destruction in vivo. Despite these hopes and extensive experimental attempts (Wright and Bernstein, 1980), antibodies have not as yet become a part of the therapeutic armamentarium.


Chronic Lymphocytic Leukemia Human Lymphocyte Autologous Bone Marrow Transplantation Free Antigen Antiidiotype Antibody 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Badger, C. C., and Bernstein, I. D., 1983, Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen, J. Exp. Med. 157:828–842.CrossRefGoogle Scholar
  2. Bernstein, I. D., Tarn, M. R., and Nowinski, R. C., 1980a, Mouse leukemia: Therapy with monoclonal antibodies against a thymus differentiation antigen, Science 207:68–71.CrossRefGoogle Scholar
  3. Bernstein, I. D., Nowinski, R. C., Tarn, M. R., McMaster, B., Houston, L. L., and Clark, E. A., 1980b, Monoclonal antibody therapy of mouse leukemia, in: Monoclonal Antibodies. Hybridomas: A New Dimension in Biological Analyses (R. H. Kennett, T. J. McKearn, and K. B. Bechtol, eds.), Plenum Press, New York, pp. 275–291.Google Scholar
  4. Boyse, E. A., Stocken, E., and Old, L. J., 1967, Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody, Proc. Natl. Acad. Sci. USA 58:954–957.CrossRefGoogle Scholar
  5. Colvin, R. B., Cosimi, A. B., Burton, R. C., Kurnick, J. T., Struzziero, C., Goldstein, G., and Russell, P. S., 1982, Anti-idiotype antibodies in patients treated with murine monoclonal antibody, OKT3, Fed. Proc. 41:363.Google Scholar
  6. Dillman, R. O., Shawler, D. L., Sobol, R. E., Collins, H. A., Beauregard, J. C., Wormsley, S. B., and Royston, I., 1982, Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia, Blood 59:1036–1045.Google Scholar
  7. Ehrlich, P., 1906, Collected Studies on Immunity, Wiley, New York, Volume 2, pp. 442–447.Google Scholar
  8. Hamlin, T. J., Abdul-Ahad, A. K., Gordon, J., Stevenson, F. K., and Stevenson, G. T., 1980, Preliminary experience in treating lymphocytic leukemia with antibody to immunoglobulin idiotypes on the cell surface, Br. J. Cancer 42:495–502.CrossRefGoogle Scholar
  9. Herlyn, D. M., Steplewski, Z., Herlyn, M. F., and Koprowski, H., 1980, Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody, Cancer Res. 40:717–721.Google Scholar
  10. Johnson, R. J., Siliciano, R. F., and Shin, H. S., 1979, Suppression of antibody-sensitized cells by macrophages: Insufficient supply or activation of macrophages within large tumors, J. Immunol. 122:379–382.Google Scholar
  11. Kaizer, H., Levy, R., Brovall, C., Civin, C. I., Fuller, D. J., Hsu, S. H., Leventhal, B. G., Miller, R. A., Milvenan, E. S., Santos, G. W., and Wharam, M. D., 1982, Autologous bone marrow transplantation in T cell malignancies: A case report involving in vitro treatment of marrow with a pan-T cell monoclonal antibody, J. Biol. Resp. Mod. 1:233–243.Google Scholar
  12. Kirch, M. E., and Hammerling, U., 1981, Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells, J. Immunol. 127:805–810.Google Scholar
  13. Köhler, G., and Milstein, C., 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature 256:495–497.CrossRefGoogle Scholar
  14. Langlois, A. G., Matthews, T., Goloson, G. J., Thiel, H. J., Collins, J. J., and Bolognesi, D. P., 1981, Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody directed macrophages mediate tumor cell destruction, J. Immunol. 126:2337–2341.Google Scholar
  15. Lanier, L. L., Babcock, G. F., Raybourne, R. B., Arnold, L. W., Warner, N. L., and Haughton, G., 1980, Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum, J. Immunol. 125:1730–1736.Google Scholar
  16. Levy, R., Dilley, J., Fox, R. I., and Warnke, R., 1979, A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies, Proc. Natl. Acad. Sci. USA 76:6552–6556.CrossRefGoogle Scholar
  17. Miller, R. A., and Levy, R., 1981, Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody, Lancet 2:226–229.CrossRefGoogle Scholar
  18. Miller, R. A., Maloney, D. G., McKillop, J., and Levy, R., 1981, In vivo effects of murine hybridoma monoclonal antibody in a patient with T cell leukemia, Blood 58:78–86.Google Scholar
  19. Miller, R. A., Maloney, D. G., Warnke, R., and Levy, R., 1982, Treatment of B cell lymphoma with monoclonal anti-idiotype antibody, New Engl. J. Med. 306:517–522.CrossRefGoogle Scholar
  20. Nadler, L. M., Stashenko, P., Hardy, R., Kaplan, W. D., Button, L. N., Kufe, D. W., Antman, K. H., and Schlossman, S. T., 1980, Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen, Cancer Res. 40:3147–3154.Google Scholar
  21. Pesando, J. M., Ritz, J., Lazarus, H., Tomaselli, K.J., and Schlossman, S. F., 1981, Fate of a common acute lymphoblastic leukemia antigen during modulation by monoclonal antibody, J. Immunol. 126:540–544.Google Scholar
  22. Ritz, J., Pesando, J. M., Sallan, S. E., Clavell, L. A., Notis-McConarty, J., Rosenthal, P., and Schlossman, S. F., 1981, Serotherapy of acute lymphoblastic leukemia with monoclonal antibody, Blood 58:141–152.Google Scholar
  23. Ritz, J., Bast, R. C., Clavell, L. A., Herhcend, T., Sallan, S. E., Lipton, J. M., Feeney, M., Nathan, D. G., and Schlossman, S. F., 1982, Autologous bone marrow transplantation in CALLA-positive ALL following in vitro treatment with J5 monoclonal antibody and complement, Lancet 2:60–63.CrossRefGoogle Scholar
  24. Sears, H. F., Mattis, J., Herlyn, D., Hayry, P., Atkinson, B., Ernst, C., Steplewski, Z., and Koprowski, H., 1982, Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumors, Lancet 1:762–765.CrossRefGoogle Scholar
  25. Shin, H. S., Hayden, M., Langley, S., Kaliss, N., and Smith, M. R., 1975, Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts, J. Immunol. 114:1255–1263.Google Scholar
  26. Shin, H. S., Economou, J. S., Pasternack, G. P., Johnson, R. G., and Hayden, M. L., 1976, Antibody-mediated suppression of grafted lymphoma, IV. Influence of time of tumor residency in vivo and tumor size upon the effectiveness of suppression by syngeneic antibody, J. Exp. Med. 144:1274–1283.CrossRefGoogle Scholar
  27. Stackpole, C. W., and Jacobson, J. B., 1978, Antigenic modulation, in: The Handbook of Cancer Immunology (H. Waters, ed.), Garland STPM, New York, pp. 55–65.Google Scholar
  28. Stevenson, G. T., Elliott, E. V., and Stevenson, F. K., 1977, Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: A therapeutic target, Fed. Proc. 36:2268–2271.Google Scholar
  29. Stratte, P. T., Miller, R. A., Amyx, H. L., Asher, D. M., and Levy, R., 1982, In vivo effects of murine monoclonal anti-human T cell antibodies in subhuman primates, J. Biol. Resp. Mod. 1:137–148.Google Scholar
  30. Wright, P. W., and Bernstein, I. D., 1980, Serotherapy of malignant disease, Prog. Exp. Tumor Res. 25:140–162.Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Ronald Levy
    • 1
  • Paul Stratte
    • 1
  • Michael Link
    • 2
  • David G. Maloney
    • 1
  • Alan Oseroff
    • 1
  • Richard A. Miller
    • 1
  1. 1.Department of MedicineStanford UniversityStanfordUSA
  2. 2.Department of PediatricsStanford UniversityStanfordUSA

Personalised recommendations